The Cooper Companies, Inc. which can be found using ticker (COO) have now 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price High/Low ranges between 560 and 280 suggesting an average Analsyt target price of $376.92. Given that the stocks previous close was at $372.30 this is indicating there is a potential upside of 1.2%. The 50 day moving average now sits at $346.44 and the 200 moving average now moves to $316.35. The total market capitalization for the company now stands at $18,305m. Visit the company website at: https://www.coopercos.com
The potential market cap would be $18,532m based on the market consensus.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
The company has a dividend yield of 0.02% with the ex dividend date set at 20-1-2023 (DMY).
Other points of data to note are a P/E ratio of 48.96, revenue per share of 68.55 and a 3% return on assets.
